Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes and Mild CKD
The Impact of Glucose Lowering Therapies on Circulating Endothelial Progenitor Cells and Its Mobilising Factor Stromal Derived Factor-1α in Patients With Type 2 Diabetes
CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men
Endothelial Effects of Basal Insulin: Detemir Versus Glargine
† Study has passed its completion date and status has not been verified in more than two years.